{
  "success": true,
  "pagesUsed": [
    3,
    9,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    23,
    34,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "01dc34a0-94e1-4ac5-9b8b-0232660ae7d1",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Screening Window",
        "relativeToFrom": {
          "id": "8e99b4e9-b6ef-4f1f-8204-b657df470fad",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e6820bd4-4565-4385-bac6-b14a4e9c745e",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P2D"
      },
      {
        "id": "timing_2",
        "name": "Washout Period",
        "type": {
          "id": "b1a35c83-7b46-49e5-8be5-4300e19b914a",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Washout Period",
        "relativeToFrom": {
          "id": "b80f37ec-1b26-41a5-b6a6-11565a993e59",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "f3b191bf-28b7-4013-8973-3cae7d5a442a",
        "instanceType": "Timing",
        "windowLower": "P3D",
        "windowUpper": "P14D"
      },
      {
        "id": "timing_3",
        "name": "Follow-up Visit Window",
        "type": {
          "id": "d69245fc-befe-4146-aa87-f882db24d021",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "89694f8c-9fe1-4893-8905-54abe642605a",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ac5849f1-527f-4feb-a85b-b83d6cc0093d",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_4",
        "name": "Discharge from CRU",
        "type": {
          "id": "70ff5ecb-29dc-4c5f-9ccc-26f8d9a39d1b",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT6H",
        "valueLabel": "6 hours",
        "relativeToFrom": {
          "id": "c4d06bbb-513c-4716-99cd-042489e34beb",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "13eb5eab-9ef1-4f60-90f4-633a5de410d3",
        "instanceType": "Timing",
        "windowLower": "PT0H",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Study Drug Administration Timing",
        "type": {
          "id": "d05075fa-fd85-4073-aab7-5ec8c3145108",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT5M",
        "valueLabel": "5 minutes",
        "relativeToFrom": {
          "id": "981633d8-b91f-4e44-8151-883480fab30a",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "1ebd8a66-1ad5-41d1-a1e5-a39deca7b8b0",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Additional Follow-up Immunogenicity Sampling",
        "type": {
          "id": "129a81bf-b079-490a-97c8-857cbff95362",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P84D",
        "valueLabel": "Day 84",
        "relativeToFrom": {
          "id": "fefcceef-91ff-4d57-9146-0bee0118b663",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "bd700a63-13cb-4fc3-a95e-c8da028e5c20",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "P7D"
      },
      {
        "id": "timing_7",
        "name": "Hypersensitivity Reaction Sample Timing",
        "type": {
          "id": "341280f9-4922-42dd-8d30-a33fb8e4fa1e",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P30D",
        "valueLabel": "Day 30",
        "relativeToFrom": {
          "id": "6963ad66-8744-461d-9b94-8bdeb58e762e",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e4907ed3-2015-4fd6-9013-06857d053d26",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Admission Rescheduling Condition",
        "instanceType": "Condition",
        "description": "Condition for rescheduling admission to the CRU on Day 1 if PG level is outside the specified range.",
        "text": "Admission can be rescheduled if PG level is not 90 to 250 mg/dL on Day 1."
      },
      {
        "id": "cond_2",
        "name": "Insulin Infusion Stop Condition",
        "instanceType": "Condition",
        "description": "Condition to stop the insulin infusion procedure.",
        "text": "Insulin infusion is stopped once bedside PG is <60 mg/dL."
      },
      {
        "id": "cond_3",
        "name": "Interim Safety Review Trigger",
        "instanceType": "Condition",
        "description": "The study will pause for a safety review after a specific number of patients have completed Period 2.",
        "text": "Safety data will be reviewed after the first 6 patients are administered LY900018 in Period 2, and the remaining patients will be dosed after confirmation of the safety."
      },
      {
        "id": "cond_4",
        "name": "Inadvertent Enrollment",
        "instanceType": "Condition",
        "description": "Condition where a patient is found to not meet enrollment criteria after being enrolled.",
        "text": "The sponsor or investigator identifies a patient who did not meet enrollment criteria and was inadvertently enrolled."
      },
      {
        "id": "cond_5",
        "name": "TE ADA Positive at Follow-up",
        "instanceType": "Condition",
        "description": "Condition for entering an additional follow-up period based on immunogenicity results.",
        "text": "Patients with TE ADA at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "cond_6",
        "name": "Patient Replacement Criteria",
        "instanceType": "Condition",
        "description": "Criteria for replacing a discontinued patient.",
        "text": "If patients discontinue from the study before completion of both periods with evaluable primary outcome for any reason, the patient may be replaced."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Transition to Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_followup",
        "toElementId": "epoch_additional_followup",
        "text": "Patients with TE ADA at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "trans_2",
        "name": "Discontinuation of Inadvertently Enrolled Patient",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If a patient is identified as inadvertently enrolled, a discussion must occur between the Lilly CP/CRP and the investigator to determine if the patient may continue in the study. If not approved, the patient will be discontinued."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient has completed all protocol-required visits, including the final follow-up visit."
      },
      {
        "id": "exit_2",
        "name": "End of Additional Follow-up",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Additional follow-up for immunogenicity ends when the titer returns to baseline or 1 year after the last dose of study treatment."
      },
      {
        "id": "exit_3",
        "name": "Withdrawal by Patient",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The patient, or legal representative, requests to be withdrawn from the study."
      },
      {
        "id": "exit_4",
        "name": "Investigator Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The investigator decides that the patient should be discontinued from the study for any reason."
      },
      {
        "id": "exit_5",
        "name": "Medical, Safety, or Regulatory Reasons",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participation in the study needs to be stopped for medical, safety, regulatory, or other reasons consistent with applicable laws, regulations, and good clinical practice."
      },
      {
        "id": "exit_6",
        "name": "Participation in Another Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Enrollment in any other clinical study involving an investigational product or enrollment in any other type of medical research judged not to be scientifically or medically compatible with this study."
      },
      {
        "id": "exit_7",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A patient will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_8",
        "name": "Study Termination by Sponsor",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The study is stopped for patient safety in the opinion of the Investigator and sponsor following the interim safety review."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Interim Safety Review Decision",
        "timepointId": "after_first_6_patients_complete_period2",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to continue or stop the study based on safety data from the first 6 patients who completed Period 2.",
        "conditionIds": [
          "cond_3"
        ]
      },
      {
        "id": "dec_2",
        "name": "Additional Follow-up Decision",
        "timepointId": "followup_visit",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision to place a patient into an additional follow-up period based on TE ADA results at the follow-up visit.",
        "conditionIds": [
          "cond_5"
        ]
      },
      {
        "id": "dec_3",
        "name": "Inadvertently Enrolled Patient Continuation Decision",
        "timepointId": "post_enrollment",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision on whether an inadvertently enrolled patient can continue in the study, requiring documented approval from the Lilly CP/CRP.",
        "conditionIds": [
          "cond_4"
        ]
      }
    ],
    "summary": {
      "timingCount": 7,
      "conditionCount": 6,
      "transitionRuleCount": 2,
      "exitCount": 8
    }
  }
}